From: EGFR associated expression profiles vary with breast tumor subtype
 | Cluster 1 | Cluster 2 | Cluster 3 | |||
---|---|---|---|---|---|---|
 | % | p-val | % | p-val | % | p-val |
EGFR | 39% | 0.1783 | 43% | 0.0091b | 38% | 0.15 |
HER2 | 26% | 0.0017 | 25% | <0.0001c | 24% | <0.0001a |
HER4* | 21% | <0.0001 | 12% | <0.0001 | 18% | <0.0001 |
TGFA | 40% | 0.0665 | 48% | 0.0002 | 47% | 0.0021 |
AREG | 22% | 0.0007c | 23% | <0.0001a | 28% | 0.064f |
EGF | 35% | 0.1380 | 25% | 0.0691 | 27% | 0.033d |
CRYAB | 35% | 0.3214f | 38% | 0.0524 | 38% | 0.0013 |
KRAS amplicon | 38% | 0.1973e | 52% | <0.0001c | 63% | <0.0001a |
KRAS gene | 27% | 0.0022a | 31% | 0.8795 | 36% | 0.14e |
HRAS | 48% | <0.0001c | 51% | <0.0001 | 47% | 0.0018 |
NRAS | 45% | 0.0362 | 56% | <0.0001c | 59% | <0.0001a |
PIK3ca | 22% | 0.0032b | 27% | 0.1415e | 30% | 0.33e |
PIK3R1 | 24% | 0.0009a | 20% | <0.0001a | 19% | <0.0001 |
AKT1 | 41% | 0.0112 | 39% | 0.0899 | 34% | 0.36 |
AKT2* | 40% | 0.0519 | 37% | 0.3524 | 33% | 0.94 |
AKT3 | 26% | 0.0004 | 33% | 0.1569 | 35% | 0.64f |
MEK1 | 39% | 0.0335 | 47% | 0.0032d | 48% | <0.0001 |
MEK2 | 58% | <0.0001a | 44% | 0.0113d | 36% | 0.55f |
ERK1 | 37% | 0.0718e | 23% | 0.0009c | 19% | <0.0001a |
ERK2 | 39% | 0.0238 | 37% | 0.3457e | 36% | 0.46e |